| |
 |
QuickScreen™ PRO 5 DSC
A Self Contained, all
Inclusive Multi-Drug, Five Panel Testing System

Minimizes exposure and handling of sample
specimens. A QuickScreen Pro 5 Panel drug
test is incorporated into the sidewalls of a specimen collection container.
The QuickScreen Pro 5 DSC system offers all the features of the standard
Pro 5 drug test card with built in
automatic timer and then adds the security of a screw top sample
container with temperature strip/ID label and the safety of specimen
handling and exposure elimination.
Cocaine
●
Opiates (Morphine/Heroin/Codeine) ●
Amphetamines
● Methamphetamine
●
THC (Marijuana) |
|
INTENDED USE
For a comprehensive
discussion on drug of abuse testing including typical detection time periods
see the DRUG
TESTING FAQ |
An
all inclusive five (5) panel immunoassay* for the
simultaneous, specimen collection and screening for multiple
drugs of abuse and their metabolites in human urine using
one self-contained testing and
sample collection device. This safe, accurate and
economical testing
system is used to obtain a rapid, visual, qualitative result indicating
drug usage or abuse within a few minutes. This product will not test for
quantitative measurements of drug concentrations in the body but will indicate
their presence at or above minimum concentrations established by the NIDA and
the World Health Organization.
●
Parental Control and Home Zero Tolerance Programs
● Random Drug
Screening of Employees
● School and Professional Athletic Programs
● Academic and Business "Drug Free Environment"
Policies
● Routine Medical Exams and Patient Profiles
● Pre-Employment Drug of Abuse Screening
● Vehicle and Heavy Equipment Operation
Programs
● Halfway House, Drug Counseling
and Treatment Programs
● Probation and Law Enforcement
|
The QuickScreen™ Pro 5 DSC
incorporates a built-in lateral flow,
multi-panel, chromo-graphic immunoassay for the detection
and identification of
amphetamines, benzoylecgonine (cocaine metabolite), methamphetamines (including
ecstasy*), opiates and opium derivatives (morphine/heroin/codeine) and
tetrahydrocannibinol-9-carboxylic acid (THC, marijuana) in human urine at the
standard minimum cut-off concentration levels based on
the following federal (NIDA) and world (WHO) guidelines:
*While Methamphetamine tests
will generally detect MDMA (Ecstasy), an MDMA specific
test is recommended when screening specifically for MDMA or Ecstasy use.
AMP
|
Amphetamines
|
1000 ng/ml
|
COC
|
Cocaine/Benzoylecgonine
|
300 ng/ml
|
THC
|
Marijuana
|
50 ng/ml
|
OPI
|
Opiates/Morphine/Heroin
|
*2000 ng/ml
|
PCP
|
Phencyclidine
|
25 ng/ml
|
M-AMP |
Methamphetamines
|
500 ng/ml
|
*National and world
regulating authorities have established and published a revised minimum
sensitivity cut-off level standard of 2000 ng/ml OPI for the Opiate class of
prescription and illicit drugs.
The QuickScreen™ Pro 5 DSC
combination specimen cup and multi-panel drug screen
maximizes the simplicity and economics of drug testing programs.
Testing is accomplished by simply obtaining a sample specimen. Thereafter the
process is completely automatic. Results are read directly from the specimen
container itself when the auto timer indicator turns red. The DSC container also
has a built-in temperature strip for confirming sample body temperature. This
provides an added security check for possible sample substitution or dilution
with tap water. The DSC test container also provides an affixed identification
label for recording test documentation of date, time, test subject ID etc.
Additionally, the screw top container can be sealed for refrigerated storage or
transport. Exposure to biological hazards is eliminated as there is no sample
handling or device transfer required in the the testing process. This
convenient, portable
one-step five panel testing device can be administered
any time, at any place, and provide a 98+% accurate and
definitive "yes or no" result in
about five minutes without the costly and time
consuming process of clinical analysis.
Automatically upon
specimen collection, the
QuickScreen™ Pro 5 DSC container begins to develop
test results. Lateral flow of the sample across the test panels will
begin and depending on the specific target drug panel, control lines and
negative test lines may be observed developing in the test panels within
thirty to sixty seconds. However, test results should not be read until
the "result ready" indicator turns red. Any line, no matter how faint,
appearing under the control line in the target drug test panel is a
negative test for that target drug or drug metabolite.
The graphic to the right shows the development of several possible
results in using the DSC container. Drugs and
drug metabolites remain at detectable levels in the human body for various periods of
time after use depending on a number of different
factors. For a brief discussion and chart regarding the half-life and
detectable periods for drugs of abuse see the
Drug FAQ.
AVAILABILITY AND ORDERING
The QuickScreen™ Pro 5 DSC is
available in packs of 1, 3, 6, 12, 25, 50
or 100 test packs. For quantities
exceeding 100 units please contact us for special volume pricing. Complete use and background information including laboratory testing results, cross reaction charts, drug characteristics and other useful information is included with each test kit.
The QuickScreen™ Pro 5 DSC is 98+% accurate when used in
strict accordance to procedural instructions and is approved by the FDA, method and claims.
Description |
Packaging |
Quantity |
Cost |
|
QuickScreen™ Pro 5
DSC
Drug Testing Cup |
Each/Sealed |
1 Test
Pack |
$16.50 |
 |
|
|
3 Test
Pack |
$39.00 |
 |
|
|
6 Test
Pack |
$69.00 |
 |
|
|
12 Test
Pack |
$120.00 |
 |
|
|
25 Test
Pack |
$200.00 |
 |
|
|
50 Test Pack |
$375.00 |
 |
|
|
100 Test Pack |
$625.00 |
 |
*If the
order buttons are absent or inoperable, please use the
pricing overview page to order. |
For bulk quantity pricing of five hundred
(500) units or more please contact us at
Customer Service
*This
immunoassay provides a preliminary, first-line analytical test result. A more specific
alternative chemical method can be used in order to obtain a confirmed laboratory
analytical result. Gas chromatography/mass spectrometry (GCIMS) has been established as
the preferred confirmatory method by the National Institute on Drug Abuse (NIDA). For
specific situations where laboratory confirmation of positive results is required, please
refer to the QuickScreen Pro Drug
At Home Test page. Clinical
consideration and professional judgment should be applied to any drug of abuse test
result, particularly when preliminary positive results are indicated.

|